Katherine A. High

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katherine A. High:

Company Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP Director Common Stock 13,341 $811,799 $60.85 10 Jun 2025 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13,000 05 Jun 2025 Direct
INCYTE CORP Director Non Qualfied Stock Option (right to buy) 9,216 10 Jun 2025 Direct

Insider Reports Filed by Katherine A. High

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INCY INCYTE CORP 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:29
CRSP CRISPR Therapeutics AG 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:30
INCY INCYTE CORP 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 12:16
CRSP CRISPR Therapeutics AG 30 May 2024 1 $0 4 Director 31 May 2024, 16:15
INCY INCYTE CORP 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:00
CRSP CRISPR Therapeutics AG 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:36
INCY INCYTE CORP 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:01
CRSP CRISPR Therapeutics AG 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 17:43
CRSP CRISPR Therapeutics AG 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:39
INCY INCYTE CORP 26 May 2021 2 $0 4 Director 28 May 2021, 07:17